跳至主要内容
临床试验/CTRI/2021/08/035755
CTRI/2021/08/035755已完成未知

Evaluation of Ashwagandha (Withania Somnifera) Standardized Extract for its effect on quality of life (QoL) in patients during post-COVID19 period: A Prospective, Randomized, Placebo-Controlled Study

D Y Patil Medical College Hospital and Research Center0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects of either gender, aged 18 to 50 years
  • 2. All adult patients aged >=18 years who present to the site for follow-up OPD
  • 3. Laboratory-confirmed COVID-19 infection with SARS-CoV-2
  • 4. Patients who agree to follow-up for up to three months.
  • 5. Subjects able to understand and complete the study questionnaires
  • 6. Subjects who sign the informed written consent

排除标准

  • 1. Patients aged below 18 years will be excluded.
  • 2. Unwilling or unable to provide written informed consent,
  • 3. Pregnant or breast-feeding women or women with positive urinary pregnancy test at screening.
  • 4. Those who cannot be relied upon to comply with the test procedures or are unwilling to give
  • informed consent

研究者

发起方
D Y Patil Medical College Hospital and Research Center

相似试验